C2N Diagnostic | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

14,004 results for “C2N Diagnostic”

Trials

View all 10756 →

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

32 participants · First posted Jul 10, 2015

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

10 participants · First posted Mar 24, 2009

Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104

3 participants · First posted Jan 29, 2018

Drugs

View all 252 →

Diagnostic T320

Defactinib companion diagnostic (Verastem Oncology/LabCorp)

Igovomab diagnostic agent

Organizations

View all 146 →

INTERNATIONAL BIO DIAGNOSTIC

United States

Diagnostic Photonics, Inc.

United States

GRIFOLS DIAGNOSTIC SOLUTIONS INC.

United States

News

View all 2850 →

Samsung Invests $10 Million in C2N Diagnostics to Advance Brain Health Diagnostics

Splash Clinical and C2N Diagnostics Partner to Revolutionize Alzheimer's Trial Recruitment with Blood-Based Biomarkers

PrecivityAD2 Blood Test Enhances Alzheimer's Diagnosis and Treatment Decisions

Page 1 of 1401